KASINGER JAMES R. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，KASINGER JAMES R.（CIK 1708172）在 1 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-10-08）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-08 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 1,990 | $27,104 |
| 2026-10-08 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 1,990 | $119,481 |
| 2026-09-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 10,400 | $141,648 |
| 2026-09-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 10,400 | $626,460 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 6,250 | $0 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 3,182 | $148,854 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 6,875 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 3,450 | $166,497 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 5,500 | $0 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 2,800 | $147,840 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 3,825 | $0 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 2,112 | $111,049 |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 买入 | 2,114 | $0 |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 卖出 | 1,076 | $71,662 |
来源：SEC Form 4 申报文件 · 截至 2026-10-08